Inventing High
Impact & High Value Medical Therapies: Methods & Case Studies in
Clinical Innovation
Zen Chu, active medical device
entrepreneur and investor and Co-founder, 3DM Inc, zen.chu@aya.yale.edu
Our evolving healthcare system is predicated on innovating new procedures and
products to maximize the benefits to patient and society. Yet each specialty in
medicine is a complex mix of current therapies, imperfect products, changing
regulatory hurdles and reimbursement limitations. What are the critical success
factors for innovations to reach the bedside and maximize clinical impact? How
can physicians and researchers map current therapies and innovations that can
reach broad adoption amid the economic challenges of our healthcare system?
This Forum will lend general summary of the process,
best practices and pitfalls in clinical innovation and the commercialization
process. An interactive panel discussion will include case studies and
perspectives from the clinician inventor, entrepreneur, venture capital
investor and corporate licensee.
Panel moderator: Richard
Anders, Managing Director, Rubin/Anders
Scientific, Inc., randers@digitalindustry.net
Panelists:
Zen Chu
Robert Creeden, Director, Partners Research Ventures,
rcreeden@partners.org
David Milne, General Partner, SV Life Sciences Advisers,
david.milne@svlsa.com
Thomas Stossel, MD, American Cancer Society Professor,
Department of Medicine, Harvard Medical School, Co-Director, Division of
Hematology, Brigham and Women's Hospital, tstossel@rics.bwh.harvard.edu